| Antiacne Clinical Trials | International Research Services, Inc. (IRSI) | OTC drugs products should undergo clinical trials of acnegenicity to evaluate the efficacy of products in the treatment of acne lesions or evaluate the acnegenic potential of the products. The expert's assessment and/or instrumental analysis reveals imp...view more OTC drugs products should undergo clinical trials of acnegenicity to evaluate the efficacy of products in the treatment of acne lesions or evaluate the acnegenic potential of the products. The expert's assessment and/or instrumental analysis reveals important statements of support: dermatologically tested, clinically proved, antiacne, minimize the appearance of pores, oil control/reduce skin greasiness/sebum control/for acne-prone skin, helps remove dirt and dead skin cells, pH balancing, hydration, sustainably strengthens skin barrier function/helps to increase skin self-defense, and reduce inflammation. Our team of experts statistically evaluates all the measures listed above to support OTC drug product manufacturers in claims evidence and to market potentially safe and effective skincare products. view less |
